• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医护人员应对癌性恶病质的经验。

Health care professionals' experiences of dealing with cancer cachexia.

机构信息

Calvary Health Care Kogarah, Kogarah, NSW, 2217, Australia.

IMPACCT-Improving Palliative, Aged and Chronic Care Through Clinical Research and Translation, Faculty of Health, University of Technology, Sydney, NSW, 2007, Australia.

出版信息

Int J Clin Oncol. 2023 Apr;28(4):592-602. doi: 10.1007/s10147-023-02300-6. Epub 2023 Feb 23.

DOI:10.1007/s10147-023-02300-6
PMID:36820948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10066081/
Abstract

BACKGROUND

Cancer cachexia (CC) is a debilitating syndrome severely impacting patients' quality of life and survivorship. We aimed to investigate the health care professionals' (HCPs') experiences of dealing with CC.

METHODS

Survey questions entailed definitions and guidelines, importance of CC management, clinician confidence and involvement, screening and assessment, interventions, psychosocial and food aspects. The online survey was disseminated through Australian and New Zealand palliative care, oncology, allied health and nursing organisations. Frequencies were reported using descriptive statistics accounting for response rates. Associations were examined between variables using Fisher's exact and Pearson's chi-square tests.

RESULTS

Over 90% of the respondents (n = 192) were medical doctors or nurses. Over 85% of the respondents were not aware of any guidelines, with 83% considering ≥ 10% weight loss from baseline indicative of CC. CC management was considered important by 77% of HCPs, and 55% indicated that it was part of their clinical role to assess and treat CC. In contrast, 56% of respondents were not confident about managing CC, and 93% believed formal training in CC would benefit their clinical practice. Although formal screening tools were generally not used (79%), 75% of respondents asked patients about specific symptoms. Antiemetics (80%) and nutritional counselling (86%) were most prescribed or recommended interventions, respectively.

CONCLUSION

This study underlines the deficiencies in knowledge and training of CC which has implications for patients' function, well-being and survival. HCP training and a structured approach to CC management is advocated for optimal and continued patient care.

摘要

背景

癌症恶病质(CC)是一种使人虚弱的综合征,严重影响患者的生活质量和生存。我们旨在调查医疗保健专业人员(HCP)处理 CC 的经验。

方法

调查问题包括定义和指南、CC 管理的重要性、临床医生的信心和参与度、筛查和评估、干预措施、心理社会和饮食方面。在线调查通过澳大利亚和新西兰的姑息治疗、肿瘤学、联合健康和护理组织进行了分发。使用描述性统计数据报告了频率,并考虑了响应率。使用 Fisher 的精确检验和 Pearson 的卡方检验检查了变量之间的关联。

结果

超过 90%的受访者(n=192)是医生或护士。超过 85%的受访者不知道任何指南,83%的人认为基线时体重减轻≥10%表明存在 CC。77%的 HCP 认为 CC 管理很重要,55%的人表示评估和治疗 CC 是其临床角色的一部分。相比之下,56%的受访者对管理 CC 没有信心,93%的人认为 CC 的正规培训将有益于他们的临床实践。尽管通常不使用正式的筛查工具(79%),但 75%的受访者会询问患者特定的症状。止吐药(80%)和营养咨询(86%)是最常开的或推荐的干预措施。

结论

这项研究强调了 CC 知识和培训的不足,这对患者的功能、幸福感和生存有影响。提倡对 HCP 进行培训,并采用结构化方法管理 CC,以实现最佳和持续的患者护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d979/10066081/149a40de0de9/10147_2023_2300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d979/10066081/149a40de0de9/10147_2023_2300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d979/10066081/149a40de0de9/10147_2023_2300_Fig1_HTML.jpg

相似文献

1
Health care professionals' experiences of dealing with cancer cachexia.医护人员应对癌性恶病质的经验。
Int J Clin Oncol. 2023 Apr;28(4):592-602. doi: 10.1007/s10147-023-02300-6. Epub 2023 Feb 23.
2
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps.癌症恶病质患者的识别与管理:评估医疗保健提供者的知识和实践差距。
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2683-2696. doi: 10.1002/jcsm.13105. Epub 2022 Oct 11.
3
Healthcare professionals' knowledge of and compliance with the ASCO/ESMO/GLIM guidelines for the diagnosis and management of cancer cachexia (CC): the ASSIST-CC baseline findings in Uganda.医疗保健专业人员对美国临床肿瘤学会(ASCO)/欧洲医学肿瘤学会(ESMO)/全球营养不良领导倡议(GLIM)癌症恶病质(CC)诊断和管理指南的了解及遵循情况:乌干达ASSIST-CC基线研究结果
Ecancermedicalscience. 2024 Jun 7;18:1712. doi: 10.3332/ecancer.2024.1712. eCollection 2024.
4
Perspectives of health care professionals on cancer cachexia: results from three global surveys.医疗保健专业人员对癌症恶病质的看法:三项全球调查结果
Ann Oncol. 2016 Dec;27(12):2230-2236. doi: 10.1093/annonc/mdw420. Epub 2016 Oct 17.
5
Challenges and solutions to cancer-related financial toxicity according to Australian health professionals: qualitative results from a national survey.澳大利亚卫生专业人员眼中与癌症相关的经济毒性的挑战和解决方案:全国调查的定性结果。
Support Care Cancer. 2023 Jul 4;31(7):441. doi: 10.1007/s00520-023-07875-4.
6
The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.基于互联网的电子学习对临床医生行为和患者结局的有效性:一项系统评价方案。
JBI Database System Rev Implement Rep. 2015 Jan;13(1):52-64. doi: 10.11124/jbisrir-2015-1919.
7
The implementation and impacts of the Comprehensive Care Standard in Australian acute care hospitals: a survey study.澳大利亚急性护理医院综合护理标准的实施和影响:一项调查研究。
BMC Health Serv Res. 2024 Jul 11;24(1):800. doi: 10.1186/s12913-024-11252-0.
8
Cancer cachexia: an overview of diagnostic criteria and therapeutic approaches for the accredited practicing dietitian.癌症恶病质:经认证的执业营养师的诊断标准和治疗方法概述。
J Hum Nutr Diet. 2021 Feb;34(1):243-254. doi: 10.1111/jhn.12811. Epub 2020 Oct 10.
9
Effect of multimodal intervention care on cachexia in patients with advanced cancer compared to conventional management (MIRACLE): an open-label, parallel, randomized, phase 2 trial.多模式干预护理对晚期癌症恶病质患者的影响与常规治疗相比(MIRACLE):一项开放标签、平行、随机、2 期试验。
Trials. 2022 Apr 11;23(1):281. doi: 10.1186/s13063-022-06221-z.
10
Perspectives of Health Care Professionals on Multimodal Interventions for Cancer Cachexia.医疗保健专业人员对癌症恶病质多模式干预的看法。
Palliat Med Rep. 2022 Dec 2;3(1):244-254. doi: 10.1089/pmr.2022.0045. eCollection 2022.

引用本文的文献

1
Healthcare professionals' knowledge of and compliance with the ASCO/ESMO/GLIM guidelines for the diagnosis and management of cancer cachexia (CC): the ASSIST-CC baseline findings in Uganda.医疗保健专业人员对美国临床肿瘤学会(ASCO)/欧洲医学肿瘤学会(ESMO)/全球营养不良领导倡议(GLIM)癌症恶病质(CC)诊断和管理指南的了解及遵循情况:乌干达ASSIST-CC基线研究结果
Ecancermedicalscience. 2024 Jun 7;18:1712. doi: 10.3332/ecancer.2024.1712. eCollection 2024.
2
The role of the nurse in meeting the educational needs for self-care in cachectic cancer patients and their family caregivers: A scoping review.护士在满足恶病质癌症患者及其家庭照顾者自我护理教育需求方面的作用:一项范围综述。
Asia Pac J Oncol Nurs. 2023 Aug 23;10(Suppl 1):100294. doi: 10.1016/j.apjon.2023.100294. eCollection 2023 Nov.
3

本文引用的文献

1
Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review.接受癌症恶病质多学科临床服务的患者生活质量和症状负担改善:回顾性观察性研究。
J Pain Symptom Manage. 2021 Sep;62(3):e164-e176. doi: 10.1016/j.jpainsymman.2021.02.034. Epub 2021 Feb 27.
2
Cancer Cachexia: Definition, Staging, and Emerging Treatments.癌症恶病质:定义、分期及新兴治疗方法
Cancer Manag Res. 2020 Jul 9;12:5597-5605. doi: 10.2147/CMAR.S261585. eCollection 2020.
3
Management of Cancer Cachexia: ASCO Guideline.
The role of pharmacists in multimodal cancer cachexia care.药剂师在多模式癌症恶病质护理中的作用。
Asia Pac J Oncol Nurs. 2023 Aug 1;10(Suppl 1):100280. doi: 10.1016/j.apjon.2023.100280. eCollection 2023 Nov.
4
The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey.日本医疗保健提供者在癌症恶病质方面开展跨专业护理的障碍:一项全国性调查。
J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):387-400. doi: 10.1002/jcsm.13384. Epub 2023 Nov 28.
5
Patient vulnerability is associated with poor prognosis following upfront hepatectomy for colorectal liver metastasis.患者脆弱性与结直肠癌肝转移行 upfront 肝切除术的预后不良相关。
Int J Clin Oncol. 2024 Jan;29(1):47-54. doi: 10.1007/s10147-023-02429-4. Epub 2023 Nov 9.
癌症恶病质的管理:ASCO 指南。
J Clin Oncol. 2020 Jul 20;38(21):2438-2453. doi: 10.1200/JCO.20.00611. Epub 2020 May 20.
4
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.癌症恶病质的研究进展:受影响器官、介质和药物干预的交叉点。
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188359. doi: 10.1016/j.bbcan.2020.188359. Epub 2020 Mar 25.
5
A comparison of four common malnutrition risk screening tools for detecting cachexia in patients with curable gastric cancer.四种常用营养不良风险筛查工具在可治愈胃癌患者中检测恶液质的比较。
Nutrition. 2020 Feb;70:110498. doi: 10.1016/j.nut.2019.04.009. Epub 2019 Apr 26.
6
Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.恶病质是否与胃肠道癌症患者的化疗毒性相关?一项前瞻性研究。
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):445-454. doi: 10.1002/jcsm.12391. Epub 2019 Mar 28.
7
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.在美国和欧盟中癌症恶病质的孤儿病地位:系统评价。
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):22-34. doi: 10.1002/jcsm.12402.
8
Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.在非自愿性体重减轻的肺癌患者中,对厌食/恶病质治疗功能性评估(FAACT)厌食/恶病质量表(A/CS)进行全面验证。
Qual Life Res. 2019 Jun;28(6):1641-1653. doi: 10.1007/s11136-019-02135-7. Epub 2019 Feb 22.
9
Quality assessment of cancer cachexia clinical practice guidelines.癌症恶病质临床实践指南的质量评估。
Cancer Treat Rev. 2018 Nov;70:9-15. doi: 10.1016/j.ctrv.2018.07.008. Epub 2018 Jul 18.
10
Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial.癌症恶病质:MENAC(恶病质的多模式运动、营养与抗炎药物治疗)试验的理论依据
BMJ Support Palliat Care. 2018 Sep;8(3):258-265. doi: 10.1136/bmjspcare-2017-001440. Epub 2018 Feb 9.